13 research outputs found
The Impact of Pravastatin Therapy on Long-Term Outcome in Patients With Metabolic Syndrome Undergoing Complete Coronary Revascularization
No full textAssociation of Low Glomerular Filtration Rate With the Incidence of Stroke in Patients Following Complete Coronary Revascularization
No full textDipyridamole Therapy Improves Long-Term Survival After Complete Revascularization in Patients With Impaired Cardiac Function
No full textPrimary Cardiac Diffuse Large B-cell Lymphoma Promptly and Safely Diagnosed with Pericardial Effusion Cytology
No full textInfluence of metabolic syndrome and diabetes on progression of calcific aortic valve stenosis
No full textDeterminants of the progression of aortic stenosis (AS) remained unclear. Metabolic syndrome (MetS) and diabetes are suspected to play an active role but literature is scarce and results conflicting. We sought to assess their impact in an ongoing prospective cohort of asymptomatic patients with at least mild AS
Impact of Fetuin-A on progression of calcific aortic valve stenosis - The COFRASA - GENERAC study
No full textAortic stenosis (AS) is an active disease, but the determinants of AS progression remain largely unknown. Low levels of Fetuin-A, a powerful inhibitor of ectopic calcification, have been linked to ectopic calcium tissue deposition but its role in AS progression has not been clearly evaluated
Prognostic impact of chronic kidney disease on 10-year clinical outcomes among patients with acute coronary syndrome
No full textPrognostic Value of Exercise-Stress Echocardiography in Asymptomatic Patients With Aortic Valve Stenosis
No full textPrognostic Value of the Metabolic Syndrome for Long-Term Outcomes in Patients Undergoing Percutaneous Coronary Intervention
No full textTherapy with statins and aspirin enhances long-term outcome of percutaneous coronary intervention
No full text
